Exfoliative cytology as a diagnostic test for basal cell carcinoma: a meta-analysis.
BACKGROUND
Exfoliative cytology is only occasionally used in clinical practice to diagnose basal cell carcinoma (BCC).


OBJECTIVE
To systematically review the literature examining exfoliative cytology as a diagnostic tool for BCC and to meta-analytically summarize the accuracy of this test.


METHODS
Diagnostic test meta-analysis. A computerized database search was made of MEDLINE (1966-2000) and EMBASE (1950-2000) using appropriately indexed terms. Hand searches of relevant journals were made. Bibliographies of relevant articles were further explored. Histopathology was used as the reference standard. A summary receiver-operating characteristic curve analysis was performed using the statistical package Meta-Test version 0.6 (J. Lau, New England Medical Center, Boston, MA, U.S.A., 1997).


RESULTS
Eight primary studies (seven English language and one Italian language) fulfilled the inclusion criteria. The pooled sample included 1261 BCCs. These studies varied greatly in methodological quality and were, in general, poor. A meta-analysis showed the pooled sensitivity to be high at 97%[95% confidence interval (CI) 94-99]. Consequently, only 3% of BCCs included were misdiagnosed as non-BCC by cytology. The corresponding pooled specificity was 86% (95% CI 80-91).


CONCLUSIONS
Exfoliative cytology probably has a high diagnostic accuracy for BCC. However, large, better designed and better reported studies are needed to ascertain the true accuracy of this technique. In the interim, this test should be considered in specific subgroups of patients in whom even a 2-mm punch biopsy may be considered inappropriate, e.g. a cosmetically sensitive site in a young person. Similarly, it should be considered when a BCC is to be treated without a diagnostic biopsy being taken, e.g. with cryotherapy.
Bakis
S
S
The Brien Walder Department of Dermatology, The Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Irwig
L
L
Wood
G
G
Wong
D
D
D002280:Basal Cell Carcinoma / Q000473:pathology*; D003581:Cytodiagnosis; D006801:Humans; D012372:ROC Curve; D012680:Sensitivity and Specificity; D012878:Skin Neoplasms / Q000473:pathology*